These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19443313)

  • 41. Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality?
    Glass B; Mangan M; Haywood A
    J Clin Pharm Ther; 2009 Apr; 34(2):161-9. PubMed ID: 19250136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacists' knowledge of the safety of antibiotics for systemic use.
    Yakimova Y
    Int J Risk Saf Med; 2015; 27 Suppl 1():S11-2. PubMed ID: 26639686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FDA seeks comments on compounding guide.
    Young D
    Am J Health Syst Pharm; 2002 Jul; 59(14):1318. PubMed ID: 12132553
    [No Abstract]   [Full Text] [Related]  

  • 44. Packaging and labeling of pharmaceutical products obtained from the internet.
    Veronin M
    J Med Internet Res; 2011 Feb; 13(1):e22. PubMed ID: 21324833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Storage conditions for stability testing of pharmaceuticals in hot and humid regions.
    Bott RF; Oliveira WP
    Drug Dev Ind Pharm; 2007 Apr; 33(4):393-401. PubMed ID: 17523004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 47. Overview of the stability and handling of recombinant protein drugs.
    Geigert J
    J Parenter Sci Technol; 1989; 43(5):220-4. PubMed ID: 2809930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postproduction Handling and Administration of Protein Pharmaceuticals and Potential Instability Issues.
    Nejadnik MR; Randolph TW; Volkin DB; Schöneich C; Carpenter JF; Crommelin DJA; Jiskoot W
    J Pharm Sci; 2018 Aug; 107(8):2013-2019. PubMed ID: 29665382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability analysis for drugs with multiple active ingredients.
    Chow SC; Shao J
    Stat Med; 2007 Mar; 26(7):1512-7. PubMed ID: 16955533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
    Castelino RL; Bajorek BV; Chen TF
    Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unapproved drugs--the drug information pharmacists' perspective.
    Giouroukakis M; Dryer M
    J Pharm Pract; 2013 Apr; 26(2):112-9. PubMed ID: 23459285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary approaches to hypertension: a call to pharmacists to promote lifestyle changes.
    Earl GL; Henstenburg JA
    J Am Pharm Assoc (2003); 2012; 52(5):637-45. PubMed ID: 23023845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; Malý J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Food and Drug Administration: Helping pharmacists ensure that patients receive high-quality medicines.
    Kremzner M
    J Am Pharm Assoc (2003); 2016; 56(2):201-2. PubMed ID: 27000171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial integrity of preservative-free alfaxalone in a multiple-use system for two storage conditions and three handling techniques.
    Whitehead MC; Vanetten CL; Jacob ME; Harrison TM
    Am J Vet Res; 2018 Jul; 79(7):704-710. PubMed ID: 29943636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When government agencies turn to unregulated drug sources: Implications for the drug supply chain and public health are grave.
    Yadav P; Weintraub RL; Stergachis A
    J Am Pharm Assoc (2003); 2018; 58(5):477-480. PubMed ID: 30077566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global perspectives on ensuring the safety of pharmaceutical products in the distribution process
.
    Jeong S; Ji E
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):12-23. PubMed ID: 29154750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.